127 related articles for article (PubMed ID: 36923997)
1. Effects of delayed hospitalization on the 3-year clinical outcomes of patients with or without diabetes who had non-ST-segment-elevation myocardial infarction and underwent new-generation drug-eluting stent implantation.
Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Kang DO; Park JY; Park SH; Jeong MH
Catheter Cardiovasc Interv; 2023 May; 101(6):1014-1027. PubMed ID: 36923997
[TBL] [Abstract][Full Text] [Related]
2. Effect of delayed hospitalization on 3-year clinical outcomes according to renal function in patients with non-ST-segment elevation myocardial infarction.
Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Park S; Kang DO; Park JY; Park SH; Jeong MH
Cardiol J; 2024; 31(2):271-284. PubMed ID: 37246457
[TBL] [Abstract][Full Text] [Related]
3. Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2022 Mar; 99(4):1022-1037. PubMed ID: 34962070
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Delayed Hospitalization in Patients with Non-ST-Segment Elevation Myocardial Infarction Undergoing New-Generation Drug-Eluting Stent Implantation.
Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Park S; Kang DO; Park JY; Choi WG; Park SH; Jeong MH
J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902769
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
[TBL] [Abstract][Full Text] [Related]
6. Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation.
Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Park S; Kang DO; Park JY; Choi WG; Park SH; Jeong MH
Sci Rep; 2023 Sep; 13(1):16067. PubMed ID: 37752278
[TBL] [Abstract][Full Text] [Related]
7. Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y;
Atherosclerosis; 2022 Mar; 344():60-70. PubMed ID: 34924173
[TBL] [Abstract][Full Text] [Related]
8. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
Byun JK; Choi BG; Rha SW; Choi SY; Jeong MH;
Atherosclerosis; 2018 Oct; 277():130-135. PubMed ID: 30212681
[TBL] [Abstract][Full Text] [Related]
9. ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2021 Dec; 100(49):e28214. PubMed ID: 34889307
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of early versus delayed invasive strategy in older adults with non-ST-segment elevation myocardial infarction.
Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Park S; Kang DO; Park JY; Park SH; Jeong MH
Sci Rep; 2022 Jul; 12(1):11429. PubMed ID: 35794207
[TBL] [Abstract][Full Text] [Related]
11. Different Statin Effects of ST-elevation Versus Non-ST-Elevation Acute Myocardial Infarction After Stent Implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Am J Med Sci; 2020 Mar; 359(3):156-167. PubMed ID: 32089157
[TBL] [Abstract][Full Text] [Related]
12. The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry.
de la Torre Hernandez JM; Moreno R; Gonzalo N; Rivera R; Linares JA; Veiga Fernandez G; Gomez Menchero A; Garcia Del Blanco B; Hernandez F; Benito Gonzalez T; Subinas A; Escaned J
Cardiovasc Revasc Med; 2019 Aug; 20(8):705-710. PubMed ID: 30414798
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Outcomes after Non-ST-Segment and ST-Segment Elevation Myocardial Infarction in Diabetic and Nondiabetic Populations.
Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Park S; Kang DO; Park JY; Park SH; Jeong MH
J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36079008
[TBL] [Abstract][Full Text] [Related]
14. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
[TBL] [Abstract][Full Text] [Related]
15. Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2021 Aug; 100(32):e26947. PubMed ID: 34397947
[TBL] [Abstract][Full Text] [Related]
16. Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From the DUTCH PEERS (TWENTE II) Randomized Trial.
van Houwelingen KG; Lam MK; Löwik MM; Danse PW; Tjon Joe Gin RM; Jessurun GA; Anthonio RL; Sen H; Linssen GCM; IJzerman MJ; Doggen CJM; von Birgelen C
Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1152-1159. PubMed ID: 27595181
[TBL] [Abstract][Full Text] [Related]
17. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction.
Sim HW; Thong EH; Djohan AH; Chen JZ; Ser JS; Loh PH; Lee CH; Chan MY; Low AF; Tay EL; Chan KH; Tan HC; Loh JP
Cardiovasc Revasc Med; 2022 Feb; 35():98-103. PubMed ID: 33893053
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
[TBL] [Abstract][Full Text] [Related]
20. Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents.
Iglesias JF; Heg D; Roffi M; Tüller D; Lanz J; Rigamonti F; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Valgimigli M; Jüni P; Windecker S; Pilgrim T
J Am Heart Assoc; 2019 Nov; 8(22):e013607. PubMed ID: 31696762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
